Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- Check5 days agoChange DetectedAn NIH banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.4%

- Check11 days agoChange DetectedThe website revision changed from v3.7.1 to v3.7.2; the clinical trial record information remains unchanged.SummaryDifference0.1%

- Check18 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.7.0 has been added to the history, and the previous revision v3.6.6 has been removed, updating the version history for the page.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.6.6 was added to the study history, replacing the previous v3.6.5 entry. This reflects a small update to the study record.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.6.5 is added to the study record history, and the older v3.6.4 entry is removed. This reflects an update to the record's version history.SummaryDifference0.1%

Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.